Carpha Opens Amr Reference Lab in Jamaica
The Caribbean Public Health Agency (CARPHA) has established an Antimicrobial Resistance (AMR) Regional Reference Laboratory in Jamaica to strengthen regional surveillance and testing for drug‑resistant infections. Jamaica’s Health and Wellness Minister Dr. Christopher Tufton says the facility will speed identification of resistant organisms, reduce dependence on overseas testing and support evidence‑based clinical decisions across CARPHA member states, including the BVI.
The Caribbean Public Health Agency (CARPHA) has opened an Antimicrobial Resistance (AMR) Regional Reference Laboratory in Jamaica, a move health officials say will strengthen the region’s ability to detect, monitor and respond to drug‑resistant infections. Jamaica’s Health and Wellness Minister, Dr.
Christopher Tufton, said the new facility will “significantly strengthen our ability to identify resistant organisms more quickly, improve surveillance, guide appropriate treatment decisions, and provide valuable evidence supporting national policy and clinical practice.” He added that the lab “reduces dependence on overseas referral testing while improving access to high‑quality laboratory services across the Caribbean.” The AMR Regional Reference Laboratory is intended to operate as a regional hub for advanced microbiology testing, surveillance, and technical support for CARPHA member states.
It will complement the work of Jamaica’s National Public Health Laboratory, hospital laboratories, infection prevention and control teams, clinicians and pharmacists while supporting Jamaica’s National Action Plan on Antimicrobial Resistance. For residents of the British Virgin Islands, the new regional capacity has practical implications.
Faster, higher‑quality testing for resistant bacteria and other pathogens can reduce delays in getting definitive results now often sent overseas, inform more precise antibiotic choices, and help clinicians manage serious infections more effectively. Through CARPHA networks and sample‑referral arrangements, smaller territories such as the BVI stand to gain quicker access to specialised testing and regional surveillance data that can influence local guidelines and stewardship programmes.
Tufton said Jamaica has been strengthening surveillance systems, promoting responsible antibiotic prescribing, advancing antimicrobial stewardship and increasing public awareness about appropriate antibiotic use. “We are not sitting down and doing nothing. What this does is add capacity, and it also allows us to do even more,” he said.
The lab will also offer technical support and regional data that can guide public health decision‑making across member states. For the BVI, that could mean improved outbreak detection, better tracking of resistant strains entering via travel or medical transfers, and targeted public education on antibiotic use.
Local health authorities will need to work with CARPHA and Jamaica’s laboratory to establish referral pathways, turnaround times and opportunities for training so the territory can fully benefit from the new regional resource.
Primary source: VINO